Mayukh Sukhatme
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mayukh Sukhatme
Mayukh Sukhatme is recorded as CFO and Board Member at Roivant Sciences Ltd. (ROIV). The proxy statement of Roivant Sciences Ltd. reports total compensation of $1,276,655 for Mayukh Sukhatme in fiscal 2025, including a base salary of $550,000. Disclosed compensation is on record for 5 fiscal years. Mayukh Sukhatme has spoken on 2 earnings calls across 1 company, most recently for Roivant Sciences Ltd. on February 1, 2023.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Roivant Sciences Ltd. (ROIV)
Proxy statement
CurrentStart not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Roivant Sciences Ltd.
Other people whose current roles at this company are on record from its filings.
- Eric Venker CEO, COO
- Matthew Gline CEO, Board Member
- Richard Pulik CFO
- Jennifer Humes Chief Accounting Officer
- Daniel Gold Board Member
- Hiroshi Nomura Board Member
- Ilan Oren Board Member
- James C. Momtazee Board Member
- Keith Manchester Board Member
- Meghan FitzGerald Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Roivant Sciences Ltd. (ROIV) | President and Chief Investment Officer | $550,000 | $1,276,655 |
| 2024 | Roivant Sciences Ltd. (ROIV) | President and Chief Investment Officer | $550,000 | $251,858,764 |
| 2023 | Roivant Sciences Ltd. (ROIV) | President and Chief Investment Officer | $550,000 | $574,560 |
| 2022 | Roivant Sciences Ltd. (ROIV) | President and Chief Investment Officer | $450,000 | $48,925,582 |
| 2021 | Roivant Sciences Ltd. (ROIV) | President and Chief Investment Officer | $450,000 | $17,488,425 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.